Beyfortus was classified as formulary, restricted to Neonatal ICU patient at discharge to home during the months of October through March

Exclusion criteria: Mother vaccinated with Abrysvo ≥ 14 days prior to birth

At HHWC, Beyfortus is offered through the Vaccines for Children (VFC) program at no cost to patients based on the following eligibility criteria:

• Medicaid/Medicaid eligible
• Uninsured
• American Indian or Alaskan Native

Reviewed: Sept 2023 (Beyfortus)

Nirsevimab (Beyfortus)

• Micromedex
• UpToDate
• Lippincott Advisor